HOME >> MEDICINE >> NEWS
Rutgers-developed biomaterial drives a technology transfer story toward success

NEW BRUNSWICK/PISCATAWAY, N.J. - The New Jersey Center for Biomaterials has generated what it hopes to be the beginning of a technology transfer success story that originated through the work of Rutgers University Professor Joachim Kohn in his search for improved biomaterials.

Kohn's new biomaterial is a bioresorbable polymer. It was exclusively licensed early in 2004 by Rutgers' Office of Corporate Liaison & Technology Transfer to a private medical device company, REVA Medical, Inc. (San Diego, Calif.), for incorporation into REVA's stent devices. Stents are tiny tubular-shaped scaffolds that are inserted into diseased arteries to keep them open. The market for such devices currently exceeds $5 billion per year.

Scientists at REVA Medical and at Kohn's Rutgers Laboratory collaborated to choose polymer compositions that would be ideally suited for use in the REVA stent. This process is usually a long and costly research project. With methods of combinatorial synthesis and computer modeling, however, Kohn's group identified a promising polymer composition in an exceptionally short time.

Based on both the rapid development from concept to prototype, and the early success of pre-clinical studies, Boston Scientific Corporation (Natick, Mass.), the world's leading stent company, announced on Nov. 16, 2004 that it had entered into a strategic alliance with REVA Medical. This alliance included a significant investment in REVA Medical.

"We regard REVA's relationship with Boston Scientific as a pivotal chapter in our technology transfer initiative," said Kohn, Board of Governors Professor of Chemistry and Chemical Biology at Rutgers and director of the center. "REVA has stent designs that add to the mechanical strength of our polymer, and with Boston Scientific's involvement, we are hopeful the successes we have seen will continue and grow."

REVA Chairman Bob Stockman said, "REVA's close collaboration with Rutgers
'"/>

Contact: Barbara Ameer
admin@njbiomaterials.org
732-445-0488
Rutgers, the State University of New Jersey
23-Nov-2004


Page: 1 2

Related medicine news :

1. Desperation drives patients
2. Yale technology translates to sonic golf training tool
3. New self-help technology set to combat eating disorders
4. PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms
5. Computer memory, MRI technology benefit from student research at UH
6. PENN study emphasizes need for national guidelines for assisted reproductive technology programs
7. Countrys first simplified maze using new ultrasound technology is done at Northwestern Memorial
8. Workshop in Kathmandu on space technology for sustainable development in mountain areas
9. University of Pennsylvania Health System launches life-saving eICU technology
10. Rehabilitation professionals in nationwide survey cite barriers to assistive technology transfer
11. FDA buys technology that identifies drug toxicity to heart

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... ... April 19, 2019 , ... According to the Environmental Working ... comes with pesticide residue. Pesticides are sprayed on produce to repel insects, but they ... make up that thin, waxy layer that covers the skin of most produce foods ...
(Date:4/19/2019)... ... April 18, 2019 , ... Residents in long-term-care nursing facilities were ... This is according to a study of U.S. men and women led ... the Brandman Research Institute (BRI) . The quality assurance study examined the high ...
(Date:4/18/2019)... ... 18, 2019 , ... Catalent, a global leader in clinical ... Clinical Supplies Group (GCSG) 2019 US Annual Conference at the Hyatt Regency Hill ... 2019. , Erin Vlack, Project Manager, will present a workshop titled “Bridging the ...
(Date:4/18/2019)... Vt. (PRWEB) , ... April 18, 2019 , ... ... Vermont’s captive regulation in a variety of areas. This year’s bill proposed several ... and improvements to the statute governing group captive investments. The many enhancements included ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... provider for their care. Through the rise of online review sites and healthcare-related ... interaction and transparency when making important purchasing decisions online. In order to elevate ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... 17, 2019 , ... Clinical trials of new cancer treatments have historically focused ... on. With advances in medical oncology and genomic characterization of tumors, we are now ... by conducting “basket trials.” This ability has created a paradigm shift in oncology trials. ...
(Date:4/17/2019)... MALDEN, Mass. (PRWEB) , ... April 17, 2019 ... ... Mark McFarland completed his 50th case using NanoFUSE Biologics. The operation took place ... Dr. McFarland performed a posterior lumbar interbody fusion and removal of hardware on ...
(Date:4/17/2019)... NEW YORK (PRWEB) , ... April 17, 2019 , ... ... Pink Bag Event® at Barclays Center on Wednesday, April 3rd. Barclays Center, ... of Brooklyn, NY. UBCF thanks Brett Yormark, CEO of BSE Global, which operates and ...
Breaking Medicine Technology:
Cached News: